Patents/Inventors

Christopher U. Missling

New York, NYUS17 patents

13 Patents

US125942562026
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-seizure Therapy
ANAVEX LIFE SCIENCES Corp.
0 cites
US125583402026
ANAVEX2-73 for the Treatment of Genetic Neurodevelopmental Disorders
ANAVEX LIFE SCIENCES Corp.
0 cites
US125333522026
Analgesic Therapeutic and Method, 1-(3-4(((1r,3s,5s)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and Salts Thereof
Anavex Life Sciences Corp.
0 cites
US123835262025
Optimized Sigma-1 Agonist Method of Responder Selection and Treatment
ANAVEX LIFE SCIENCES Corp.
0 cites
US122854032025
A2-73 as a Therapeutic for Insomnia, Anxiety and Agitation
Anavex Life Sciences, Corp.
0 cites
US122800342025
Sigma-1 Receptor Agonist Systolic Blood Pressure Therapy
Anavex Life Sciences Corp.
0 cites
US121801742024
A2-73 Crystalline Polymorph Compositions of Matter and Methods of Use Thereof
ANAVEX LIFE SCIENCES Corp.
0 cites
US121382402024
Treatment of Cardiac Dysfunction
Anavex Life Sciences Corp.
0 cites
US118965902024
Analgesic Therapeutic and Method, 1-(3-4(((1r,3s,5s)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and Salts Thereof
ANAVEX LIFE SCIENCES Corp.
0 cites
US118396002023
Neurodevelopmental Disorder Therapy
Anavex Life Sciences Corp.
0 cites
US118132422023
A2-73 as a Therapeutic for Insomnia, Anxiety, and Agitation
Anavex Life Sciences Corp.
0 cites
US116908212023
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-seizure Therapy
ANAVEX LIFE SCIENCES Corp.
0 cites
US116229552023
Sigma-1 Receptor Agonist Systolic Blood Pressure Therapy
ANAVEX LIFE SCIENCES Corp.
0 cites